Platelet Inhibition to Target Reperfusion Injury: The PITRI Trial
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Cangrelor (Primary)
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Proof of concept; Therapeutic Use
- Acronyms PITRI
- 03 Apr 2024 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified April 2022).
- 19 Apr 2022 Planned End Date changed from 1 Jul 2020 to 1 Dec 2022.
- 19 Apr 2022 Planned primary completion date changed from 1 Jul 2020 to 1 Dec 2022.